Sentence examples for track screening from inspiring English sources

One pilot tested the program among 500 low-income Latinos, but relied on manual medical chart review to identify patients and track screening outcomes [ 4].

Although clinics reported that they recommended and referred patients for screening routinely, there were no systems in place to track screening results.

Dr. Bogden is dismayed that in April the state's first comprehensive attempt to track lead screening found that 5percentt of those tested -- more than 6,800 children -- had too much lead in their blood.

The impacted developers have been using a variety of methods to track screen time, as there has not been any official means of tracking this data.

Its tools help users track screen time and app usage, and include new features like a "shush" mode which turns on Do Not Disturb by flipping the phone over, and a "wind down," color reduction mode for bedtime.

Using that, parents can limit and track screen time on the device, assuring that kids are using the device to read an actual book, in addition to various other media consumption.

The clinic has also adopted fast-track screening procedures in which mammograms are read in batches and women are called back with results within 72 hours.

CTV-RNAi vector would be relevant for fast-track screening of candidate sequences for RNAi-mediated pest control.

Frederic Cussigh, head of the United Nations refugee program in the northern Iraqi town of Irbil, said his organization arranged to fast-track screening for women and children, but that the rest must be screened carefully because Islamic State "could infiltrate with the civilians either to hide or perpetrate some attacks later on".

With docetaxel as effective chemotherapy for hormone refractory prostate cancer (HRPC), the number of new treatment combinations for HRPC is expanding demanding a fast-track screening system.

The introduction of docetaxel as effective treatment for HRPC has generated the need for fast-track screening to select new therapeutic agents and potential treatment combinations, thereby facilitating the proper design of phase II and phase III clinical trials.